scholarly journals Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation

2015 ◽  
Vol 36 (2) ◽  
pp. 111 ◽  
Author(s):  
VenkateshViswanath Kamath ◽  
Shruti Krishnamurthy ◽  
KrishnanandP Satelur ◽  
Komali Rajkumar
2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Nezar Boreak

Oral submucous fibrosis (OSMF) is considered a premalignant condition characterized by aggressive fibrosis of the submucosal tissues of the oral cavity reflecting its malignant transformation potential. Activation of transforming growth factor beta (TGF-β) signaling has been reported to lead increased collagen production and fibrosis. Recently, significant upregulation of TGF-β1 has been reported in OSMF as compared to normal tissues. Therefore, inhibition of the TGF-β1 may pave for the development of therapeutics of OSMF. Based on the structure-assisted drug designing, we found “silmitasertib” as potent inhibitor of TGF-β1. We suggest that this molecule can be validated and implemented for the treatment of OSMF.


2020 ◽  
Vol 10 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Arpita Rai ◽  
Tanveer Ahmad ◽  
Shama Parveen ◽  
Saba Parveen ◽  
Md Imam Faizan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document